Changes related to "Epirubicin (Ellence)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 23:33, 16 December 2018
   
Page name:

16 December 2018

     22:21  Breast cancer‎‎ (10 changes | history) . . (+10,673). . [Jwarner‎ (10×)]
 m    22:21 (cur | prev) . . (+1,366). . Jwarner (talk | contribs) (EP {{#subobject:e10567|Regimen=1}})
 m    21:24 (cur | prev) . . (+860). . Jwarner (talk | contribs) (FEC {{#subobject:3613b7|Regimen=1}})
      20:00 (cur | prev) . . (+1,759). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:1216fd|Regimen=1}})
 m    19:55 (cur | prev) . . (+2). . Jwarner (talk | contribs)
 m    18:01 (cur | prev) . . (+996). . Jwarner (talk | contribs) (FEC {{#subobject:3613b7|Regimen=1}})
      14:40 (cur | prev) . . (+1,658). . Jwarner (talk | contribs) (Doxorubicin pegylated liposomal monotherapy {{#subobject:2b08a6|Regimen=1}})
 m    12:44 (cur | prev) . . (+828). . Jwarner (talk | contribs) (Docetaxel & Bevacizumab {{#subobject:65222f|Regimen=1}})
 m    10:51 (cur | prev) . . (+643). . Jwarner (talk | contribs) (References)
      10:45 (cur | prev) . . (+1,661). . Jwarner (talk | contribs) (EC {{#subobject:3e1e8f|Regimen=1}})
 m    10:01 (cur | prev) . . (+900). . Jwarner (talk | contribs) (Capecitabine & Docetaxel {{#subobject:9d5b30|Regimen=1}})
 m   21:54  Gastric cancer‎‎ (5 changes | history) . . (+4,918). . [Jwarner‎ (5×)]
 m    21:54 (cur | prev) . . (+830). . Jwarner (talk | contribs) (Fluorouracil monotherapy {{#subobject:588907|Regimen=1}})
 m    19:33 (cur | prev) . . (+877). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:6df2c0|Regimen=1}})
 m    11:42 (cur | prev) . . (+848). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:6df2c0|Regimen=1}})
 m    10:25 (cur | prev) . . (+829). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:6df2c0|Regimen=1}})
 m    08:44 (cur | prev) . . (+1,534). . Jwarner (talk | contribs) (Cisplatin & S-1 {{#subobject:252c51|Regimen=1}})
     10:35  Esophageal cancer‎ (diff | hist) . . (+1,441). . Jwarner (talk | contribs) (Neoadjuvant induction therapy)

15 December 2018

     22:51  Breast cancer‎‎ (5 changes | history) . . (+13,632). . [Jwarner‎ (5×)]
 m    22:51 (cur | prev) . . (+827). . Jwarner (talk | contribs) (FEC {{#subobject:3613b7|Regimen=1}})
 m    22:15 (cur | prev) . . (+8,722). . Jwarner (talk | contribs)
 m    19:51 (cur | prev) . . (+959). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    19:27 (cur | prev) . . (+826). . Jwarner (talk | contribs) (iddEPC {{#subobject:28ad40|Regimen=1}})
      19:23 (cur | prev) . . (+2,298). . Jwarner (talk | contribs) (EC {{#subobject:8d8dbe|Regimen=1}})
 m   22:27  Gastric cancer‎‎ (2 changes | history) . . (+1,927). . [Jwarner‎ (2×)]
 m    22:27 (cur | prev) . . (+797). . Jwarner (talk | contribs) (S-1 monotherapy {{#subobject:a12a2a|Regimen=1}})
 m    20:20 (cur | prev) . . (+1,130). . Jwarner (talk | contribs) (Capecitabine monotherapy {{#subobject:a9eb0b|Regimen=1}})
 m   22:09  Soft tissue sarcoma‎ (diff | hist) . . (+816). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}})
 m   17:05  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+622). . Jwarner (talk | contribs) (References)
 m   09:22  Small cell lung cancer‎ (diff | hist) . . (+31). . Jwarner (talk | contribs) (CEV & RT {{#subobject:a3e998|Regimen=1}})

14 December 2018

 m   22:18  Osteosarcoma‎ (diff | hist) . . (+850). . Jwarner (talk | contribs) (Cisplatin & Doxorubicin {{#subobject:418c69|Regimen=1}})
 m   21:15  Esophageal cancer‎ (diff | hist) . . (+203). . Jwarner (talk | contribs)

13 December 2018

 m   22:18  Breast cancer‎ (diff | hist) . . (+7,116). . Jwarner (talk | contribs)

12 December 2018

 m   21:38  Testicular cancer‎ (diff | hist) . . (+2,037). . Jwarner (talk | contribs)
 m   11:56  Cholangiocarcinoma‎ (diff | hist) . . (+1,305). . Jwarner (talk | contribs) (All lines of therapy)
 m   11:52  Gastric cancer‎ (diff | hist) . . (+808). . Jwarner (talk | contribs) (CX {{#subobject:2bd34d|Regimen=1}})
     09:05  Small cell lung cancer‎‎ (3 changes | history) . . (+4,022). . [Jwarner‎ (3×)]
 m    09:05 (cur | prev) . . (+8). . Jwarner (talk | contribs) (Carboplatin, Etoposide, Atezolizumab {{#subobject:760b97|Regimen=1}})
 m    09:04 (cur | prev) . . (+1,503). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:e2a180|Regimen=1}})
      09:02 (cur | prev) . . (+2,511). . Jwarner (talk | contribs) (Carboplatin & Etoposide {{#subobject:de3ba6|Regimen=1}})

10 December 2018

 m   15:26  Hodgkin lymphoma‎‎ (2 changes | history) . . (+1,691). . [Jwarner‎ (2×)]
 m    15:26 (cur | prev) . . (+1,112). . Jwarner (talk | contribs) (Flu-Mel, then allo HSCT {{#subobject:6f8499|Regimen=1}})
 m    13:06 (cur | prev) . . (+579). . Jwarner (talk | contribs) (MOPP {{#subobject:bcde0|Regimen=1}})
 m   12:52  Gastric cancer‎ (diff | hist) . . (+13). . Jwarner (talk | contribs)
 m   12:50  Esophageal cancer‎ (diff | hist) . . (+1,289). . Jwarner (talk | contribs)